Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.
Trump seizes on Gates' memo downplaying climate change apocalypse, sparking debate over priorities ahead of COP30.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.
Trump seizes on Gates' memo downplaying climate change apocalypse, sparking debate over priorities ahead of COP30.